Chairperson(s) : Sang-Hak Lee (Yonsei University, Republic of Korea)
Panel(s) : Jae Hyoung Park (Korea University, Republic of Korea)
-
Clinical and molecular risk factors in severe FH
Soo Heon Kwak Seoul National University, Republic of Korea 14:40~15:00 - Discussion 15:00~15:10
-
The current status of HoFH in Japan
Mariko Harada-Shiba Osaka Medical & Pharmaceutical University, Japan 15:10~15:30 - Discussion 15:30~15:40
-
Prevalence and clinical characteristics of FH in patients with ACS in Japan: insight from the EXPLORE-J study
Yasuaki Takeji Kanazawa University, Japan 15:40~15:48 - Q&A 15:48~15:55
-
Omics markers of FH
Dae Young Cheon Hallym University, Republic of Korea 15:55~16:03 - Q&A 16:03~16:10
Chairperson(s) : Sang-Hak Lee (Yonsei University, Republic of Korea)
Panel(s) : Kyuho Kim (The Catholic University of Korea, Republic of Korea)
-
Polygenic background modifies risk of CAD in individuals with HeFH
Injeong Shim Massachusetts General Hospital, Broad Institute of MIT and Harvard, USA 16:20~16:40 - Discussion 16:40~16:50
-
Differential diagnosis of severe hypercholesterolemia in clinical practice
Hayato Tada Kanazawa University, Japan 16:50~17:10 - Discussion 17:10~17:20
-
Evaluation of achilles tendon thickness by ultrasonography as a predictor of coronary artery disease severity in non-familial hypercholesterolemia patients
Shimpei Fujioka Osaka Medical and Pharmaceutical University, Japan 17:20~17:28 - Q&A 17:28~17:35
